Exxel Pharma, INC. — Form D

Exxel Pharma, INC. of Aurora, CO, a company, filed a Form D exempt-offering notice with the SEC on 2024-12-02. The offering totals $600K, of which $600K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2024-12-02
• Form: D
• Accession: 0002046638-24-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $600K
• Amount sold: $600K
• Minimum investment: $125K
• Investors: 1
• Date of first sale: 2024-11-20
• Security types: debt
• Revenue range: $1 - $1,000,000
• SEC file number: 021-530836

Issuer

• Name: Exxel Pharma, INC.
• CIK: 0002046638
• Entity type: Corporation
• Jurisdiction: BRITISH COLUMBIA, CANADA
• Address: 12635 East Montview Blvd, Aurora, CO, 80045
• Phone: 720-261-1109

Officers, directors & promoters (3)

More

• CIK 2046638 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search